This is not a government agency sharing risk, it’s a government agency assuming virtually all of the risk associated with the higher premium costs due to the rebate rule. In other words, a bailout.
While such costs represent a small fraction of overall spending on health care, several dynamics help the prescription drug issue gain disproportionate attention.
Here’s a solution: stop focusing on trying to control prescription drug prices, and start paying attention to who’s paying them.
In fact, Sen. Bernie Sanders is one of the most blatantly dishonest politicians on either side of the aisle, particularly on health care.
While the public hold little sympathy for Big Pharma, when the drug industry suffers, people suffer. And when Big Pharma wins, people win.
On Wednesday, a Senate committee will hold a hearing on President Trump’s appointment of Dr. Scott Gottlieb as commissioner of the Food and Drug Administration.
Watch out for five misguided attacks to persuade the public that government intervention in the pharmaceutical industry is necessary. Actually, it will make things worse.
- The Student Debt You Willingly Took On Is Not My Problem To SolveApparently, the majority of Democratic presidential concontinue reading >
- My Son’s Freshman Orientation At Virginia Tech Was Full Of Leftist PropagandaNow that I have witnessed college propaganda firsthand,continue reading >
- Israel Has Every Right To Block Rashida Tlaib And Ilhan OmarIsraeli officials have decided to block Reps. Rashida Tcontinue reading >